{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:18:37Z","timestamp":1771845517793,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T00:00:00Z","timestamp":1496534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.nefro.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T13:16:01Z","timestamp":1498914961000},"page":"179-189","source":"Crossref","is-referenced-by-count":5,"title":["Cambios de la funci\u00f3n renal tras la suspensi\u00f3n de an\u00e1logos de vitamina D en la enfermedad renal cr\u00f3nica avanzada"],"prefix":"10.1016","volume":"38","author":[{"given":"Francisco","family":"Caravaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Caravaca-Font\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2017.05.012_bib0230","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0235","first-page":"716","article-title":"Vitamina D y proteinuria: Revisi\u00f3n cr\u00edtica de las bases moleculares y de la experiencia cl\u00ednica","volume":"33","author":"P\u00e9rez-G\u00f3mez","year":"2013","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2017.05.012_bib0240","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: A systematic review","volume":"24","author":"De Borst","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0245","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial","volume":"376","author":"De Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2017.05.012_bib0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2010.543","article-title":"Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: A downward spiral in kidney disease","volume":"79","author":"Dusso","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.2009.175","article-title":"Renoprotective effects of vitamin D analogs","volume":"78","author":"Li","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0265","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2017.05.012_bib0270","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/ndt\/17.12.2132","article-title":"22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats","volume":"17","author":"Hirata","year":"2002","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0275","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/039463200501800422","article-title":"Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis","volume":"18","author":"Migliori","year":"2005","journal-title":"Int J Immunopathol Pharmacol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0280","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy","volume":"17","author":"Tan","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD-the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2017.05.012_bib0290","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.nefro.2017.05.012_bib0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneph.2013.74","article-title":"The effect of vitamin D status on risk factors for cardiovascular disease","volume":"9","author":"Gunta","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0300","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0305","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","article-title":"Oral active vitamin D is associated with improved survival in hemodialysis patients","volume":"74","author":"Naves-D\u00edaz","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0310","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/ndt\/gfn592","article-title":"The survival advantage for haemodialysis patients taking vitamin D is questioned: Findings from the Dialysis Outcomes and Practice Patterns Study","volume":"24","author":"Tentori","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0315","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: Vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.nefro.2017.05.012_bib0325","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(76)92220-0","article-title":"Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure","volume":"1","author":"Tougaard","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2017.05.012_bib0330","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(78)92702-2","article-title":"Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol","volume":"2","author":"Christiansen","year":"1978","journal-title":"Lancet."},{"key":"10.1016\/j.nefro.2017.05.012_bib0335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/mlc.2002.127371","article-title":"Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure","volume":"140","author":"Sanai","year":"2002","journal-title":"J Lab Clin Med."},{"key":"10.1016\/j.nefro.2017.05.012_bib0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.nefro.2017.05.012_bib0345","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ki.2012.311","article-title":"Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease","volume":"83","author":"De Boer","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2011.09.014","article-title":"Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: A randomized controlled trial","volume":"59","author":"Liu","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.05.012_bib0355","first-page":"98","article-title":"Renal function during calcitriol therapy in chronic renal failure","volume":"33","author":"Bertoli","year":"1990","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0360","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1365-2133.1996.tb07945.x","article-title":"Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis","volume":"134","author":"Perez","year":"1996","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0365","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ki.2011.207","article-title":"Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate","volume":"80","author":"Agarwal","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0370","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.nefro.2017.05.012_bib0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00365518109092020","article-title":"Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency","volume":"41","author":"Br\u00f8chner-Mortensen","year":"1981","journal-title":"Scand J Clin Lab Invest."},{"key":"10.1016\/j.nefro.2017.05.012_bib0380","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1985.10","article-title":"A method for estimating nitrogen intake of patients with chronic renal failure","volume":"27","author":"Maroni","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0385","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2215\/CJN.05030610","article-title":"Equations to estimate creatinine excretion rate: The CKD epidemiology collaboration","volume":"6","author":"Ix","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.05.012_bib0390","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0395","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpedi.1984.02140500031011","article-title":"Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol","volume":"138","author":"Hymes","year":"1984","journal-title":"Am J Dis Child."},{"key":"10.1016\/j.nefro.2017.05.012_bib0400","first-page":"317","article-title":"Calcium sensing in the renal tubule","volume":"30","author":"Toka","year":"2015","journal-title":"Physiology (Bethesda)."},{"key":"10.1016\/j.nefro.2017.05.012_bib0405","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefro.2017.05.012_bib0410","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ndt\/gfp547","article-title":"Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease","volume":"25","author":"Frimodt-M\u00f8ller","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0415","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfp568","article-title":"Is therapy of people with chronic kidney disease ONTARGET?","volume":"25","author":"Mann","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0420","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0425","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.transproceed.2005.02.009","article-title":"Effect of parathyroidectomy on renal graft function","volume":"37","author":"Garc\u00eda","year":"2005","journal-title":"Transplant Proc."},{"key":"10.1016\/j.nefro.2017.05.012_bib0430","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/ndt\/gfh892","article-title":"Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: A single centre study","volume":"20","author":"Evenepoel","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0435","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfl583","article-title":"Decreased renal transplant function after parathyroidectomy","volume":"22","author":"Schwarz","year":"2007","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0440","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ctr.12099","article-title":"Impact of post-kidney transplant parathyroidectomy on allograft function","volume":"27","author":"Parikh","year":"2013","journal-title":"Clin Transplant."},{"key":"10.1016\/j.nefro.2017.05.012_bib0445","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ki.1984.73","article-title":"Parathyroid and bone response of the diabetic patient to uremia","volume":"25","author":"Vincenti","year":"1984","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.05.012_bib0450","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699517301352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699517301352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T17:09:10Z","timestamp":1530032950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699517301352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0211699517301352"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2017.05.012","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}